Exane Asset Management’s Medicines Co MDCO Stock Holding History

Exane Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,000	Closed	-$1.27M	–	31
2019 Q4	$1.27M	Buy	+15,000	New	+$1M	1.56%	16

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Exane Asset Management's MDCO Position: Q1 2020 in Review

Exane Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 15,000 shares — an estimated $1.27M sold.

Exane Asset Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $1.27M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Exane Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Exane Asset Management sold 15,000 Medicines Co shares in Q1 2020, an estimated $1.27M.
Exane Asset Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Exane Asset Management's Medicines Co position peaked at $1.27M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Exane Asset Management's 13F filing for Q1 2020, filed 22 Apr 2020.